PPD Development LP
PPD Development LP received $50.5M in federal prime contract obligations in the 12 months ending Oct 5, 2026, up 774.9% from −$7.5M the year before, and $392.0M since FY2022. Its largest customer is the Department of Health and Human Services.
See 6 contracts ending in the next 18 months ↓Contractor details
- Unique Entity ID (UEI)
- ZANENSW6C665
- CAGE code
- 3FAW2
- Doing business as
- P P D
- Headquarters
- Wilmington, NC
- Business size
- Other Than Small Business
- Parent company
- Pharmaceutical Product Development, LLC (UEI XY1WVYRYCZB5)
As recorded on this UEI's most recent prime contract action in USAspending.gov. Confirm current registration and certifications in SAM.gov.
Obligations by fiscal year
Net prime contract obligations by federal fiscal year.
Markets where it ranks top 10
Agency and NAICS markets where this UEI is one of the ten largest primes in the latest 12 months.
Top agencies
Funding agencies ranked by obligations since FY2022.
| Funding agency | Latest 12 mo | Since FY2022 |
|---|---|---|
| Department of Health and Human Services | $50.5M | $390.3M |
| Department of Defense | $0 | $1.8M |
Top NAICS codes
Industry codes agencies recorded on this contractor's awards, since FY2022.
| NAICS | Industry | Latest 12 mo | Since FY2022 |
|---|---|---|---|
| 541714 | Research and Development in Biotechnology (except Nanobiotechnology) | $40.1M | $339.2M |
| 541715 | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | $8.0M | $167.3M |
| 541711 | Research and Development in Biotechnology | −$370K | $4.8M |
| 541720 | Research and Development in the Social Sciences and Humanities | $802K | $1.2M |
| 541690 | Other Scientific and Technical Consulting Services | $0 | $1.1M |
| 541990 | All Other Professional, Scientific, and Technical Services | −$11K | $1.0M |
What it sells
Product and service codes (PSC) on this contractor's awards, since FY2022.
| PSC | Description | Since FY2022 |
|---|---|---|
| AN12 | Health R&D services; Health Care services; Applied Research | $382.5M |
| AN42 | Health R&D services; Health Care - other; Applied Research | $130.2M |
| R499 | Support- professional: Other | $2.6M |
| AN11 | Health R&D services; Health Care services; Basic Research | $2.6M |
| AJ53 | R&D- General Science/technology: Life Sciences (Advanced Development) | $1.8M |
| AJ11 | General Science and Technology R&D services; General Science and technology; Basic Research | $1.3M |
Contracts ending in the next 18 months
This contractor's largest awards whose current period of performance ends soon. Options and extensions often move these dates.
| Award | Agency | Obligated | Current end |
|---|---|---|---|
| 75N93022C00001 | Department of Health and Human Services REGULATORY MANAGEMENT CENTER (RMC) | $17.4M | Oct 31, 2026 |
| 75N93026F00001 | Department of Health and Human Services DAIDS MONITORING FOR 1 PHASE III STUDY: A5300B/I2003B (PHOENIX) | $3.1M | Dec 14, 2026 |
| 75N93024F00001 | Department of Health and Human Services NIAID CLINICAL SITE MONITORING (NCSM) | $73.2M | Jan 31, 2027 |
| 75N98026F00001 | Department of Health and Human Services TASK ORDER AWARD- PHASE I CLINICAL TRIALS FOR THE DEVELOPMENT OF NEUROTHERAPEUTICS- DTI-117 IN HEALTHY VOLUNTEERS/SAD AND MAD CT | $2.0M | Apr 28, 2027 |
| 75N93022C00014 | Department of Health and Human Services NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES (NIAID) CLINICAL SITE MONITORING CENTER (CSMC) | $36.4M | Jun 29, 2027 |
| 75N93024F00002 | Department of Health and Human Services COMPREHENSIVE AND RAPID RESPONSE FOR NIAID RESEARCH PROGRAMS HIV AND OTHER INFECTIOUS DISEASES CLINICAL RESEARCH SUPPORT SERVICES (CRSS) | $26.1M | Aug 14, 2027 |
Recent awards
This contractor's newest prime contract awards, most recent first.
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| 75N98026F00001 | Department of Health and Human Services TASK ORDER AWARD- PHASE I CLINICAL TRIALS FOR THE DEVELOPMENT OF NEUROTHERAPEUTICS- DTI-117 IN HEALTHY VOLUNTEERS/SAD AND MAD CT | $116K | Jun 26, 2026 |
| 75N93026F00001 | Department of Health and Human Services DAIDS MONITORING FOR 1 PHASE III STUDY: A5300B/I2003B (PHOENIX) | $3.1M | Dec 10, 2025 |
| 75N95025F00001 | Department of Health and Human Services TASK ORDER75N95025F00001 TO4 BLUEPRINT MEDTECH PREPARATION OF PRE-SUBMISSION SUPPORT FOR PILOT PARTICIPANT. | $5K | Dec 20, 2024 |
| 75F40124C00134 | Department of Health and Human Services BAA-FY24C3CP5-UNDERSTANDING HETEROGENEITY IN PREFERENCES FOR CLINICAL TRIAL PARTICIPATION IN DIVERSE PATIENT POPULATIONS. | $498K | Sep 24, 2024 |
| 75F40124C00117 | Department of Health and Human Services FDABAA-24-00123, REF # FY24C1EP6, CARDIOVASCULAR-KIDNEY-METABOLIC (CKM) SYNDROME PATIENT-REPORTED OUTCOME (PRO) BURDEN MEASURE | $724K | Sep 11, 2024 |
| 75N93024F00002 | Department of Health and Human Services COMPREHENSIVE AND RAPID RESPONSE FOR NIAID RESEARCH PROGRAMS HIV AND OTHER INFECTIOUS DISEASES CLINICAL RESEARCH SUPPORT SERVICES (CRSS) | $8.5M | Aug 7, 2024 |
| 75N95024F00002 | Department of Health and Human Services PHASE I RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED STUDY TO ASSESS SAFETY, TOLERABILITY, AND PHARMACOKINETICS | $306K | Jul 15, 2024 |
| 75N95024F00001 | Department of Health and Human Services FIRST IN HUMAN RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED SINGLE ASCENDING DOSE (SAD) PHASE I STUDY | $428K | Jul 1, 2024 |
Prime contracts (award types A–D) from USAspending.gov through Oct 5, 2026. Subcontracts are not included. Net obligations include deobligations and corrections.
Ready to connect your pursuit work?
GovEagle gives BD directors, capture managers, and proposal teams one AI workspace from pipeline through proposal, with CMMC/FedRAMP Certified compliance built in.